US Follows WHO: Monkeypox Is a Public Health Emergency
The declaration will allow more funds for control of and resources for the disease.
Monkeypox (Adobe Stock)
This article was originally published in Contagionlive.com.
US Health Secretary Xavier Becerra declared a national public health emergency for monkeypox.
“In light of evolving circumstances on the ground, I am declaring a public health emergency on #monkeypox. We are prepared to take our response to the next level in addressing this virus. We urge every American to take monkeypox seriously," Becerra, tweeted on August 4.
The declaration mobilizes the response and opens up federal funding to address the virus.
As of yesterday, there has been 6617 confirmed cases with California and New York having the most cases. Earlier this week, California Governor Gavin Newsom declared a state of emergency with regards to the monkeypox outbreak. This came on the heels of San Francisco and New York City declaring states of emergency along with New York State’s declaration that monkeypox is an "imminent threat to public health," over the last week. Shortly before that, World Health Organization declared monkeypox a “global health emergency.”
The US federal agencies are making vaccines and treatment available. For example, CDC and FDA have developed a process to help clinicians secure an antiviral therapy, tecovirimat (Tpoxx), for treatment for patients with monkeypox. This falls under the expanded access investigational new drug (EA-IND). Clinicians can begin the process to secure tecovirimat by going here.
Tecovirimat is manufactured by SIGA Technologies, and is approved for smallpox and is being studied for monkeypox treatment. Infection Control Today®’s (ICT®’s) sister publication, Contagion Live, spoke with SIGA Technologies Chief Scientific Officer Dennis Hruby, PhD, recently about the therapy.
The federal government has also been sending out vaccines to prevent the spread of monkeypox. At this point in time, it has been reported that only people who are close personal contacts of people who have contracted the virus are eligible to get access to the vaccines.
ICT® gives details about monkeypox, what it is and how it is spread, here.
Antibiotic Stewardship in Long-Term Care: Leveraging McGeer and Loeb Criteria for Better Outcomes
February 28th 2025Antibiotic stewardship in long-term care facilities relies on McGeer and Loeb criteria to guide infection surveillance and appropriate prescribing, ensuring better outcomes for residents and reducing resistance.
Oral Parasites and Periodontal Disease: The Hidden Threat to Dental Health
February 28th 2025Entamoeba gingivalis and Trichomonas tenax are protozoan parasites linked to periodontal disease. Emerging research highlights their role in oral inflammation, tissue destruction, and worsening gum disease.
Rare Disease Month: Nipah Virus—It Is From Bats!
February 28th 2025For Rare Disease Month, Rebecca Leach, MPH, BSN, RN, CIC, writes on Nipah virus, a rare but deadly zoonotic disease that poses a significant public health threat. With high mutation potential and no cure, prevention and awareness are critical.
Beyond Civil Rights: Black Trailblazers in Medicine and Infection Prevention
February 28th 2025Black History Month should celebrate pioneers like Drs William Hinton, Daniel Hale Williams, and Charles Drew, whose medical breakthroughs revolutionized infection prevention, surgery, and blood preservation.
The Latest on CLABSIs and CAUTIs: Evidence-Based Approaches for Infection Prevention
February 27th 2025Health care–associated infections like CLABSIs and CAUTIs threaten patient safety. Learn evidence-based strategies, new technologies, and prevention protocols to reduce these infections and improve outcomes.
